Physician profile
Ashley V Marr
NPI 1396375366
$3,783.09
in general payments reported to CMS, 2019-2025
23 companies · $428 in 2025
The $428 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $603 · 2022: $1,395 · 2023: $694 · 2024: $664 · 2025: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,786.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,785.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,073.67 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $814.67 | 2021-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $431.40 | 2021-2025 | Eliquis, Camzyos |
| Boston Scientific Corporation | $284.94 | 2021-2025 | Watchman Flx, Varithena Administration Pack, Watchman Access System |
| Abiomed | $159.09 | 2023-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $141.79 | 2021-2022 | |
| Astellas Pharma US INC | $132.00 | 2022 | |
| Medtronic, INC. | $118.65 | 2022-2025 | Selectsecure, Hawkone, Corevalve Evolut R |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $110.55 | 2023-2025 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $96.78 | 2022-2023 | Opsumit, Uptravi |
| Merck Sharp & Dohme LLC | $68.85 | 2022 | |
| Pfizer INC. | $55.42 | 2022-2024 | |
| Edwards Lifesciences Corporation | $54.43 | 2021 | |
| Amgen INC. | $45.78 | 2021-2022 | |
| Teleflex LLC | $34.97 | 2023-2024 | Supercross, Guideliner |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $34.81 | 2021-2022 | |
| Inspire Medical Systems, INC. | $23.81 | 2024 | Inspire |
| Getinge USA Sales, LLC | $23.61 | 2023 | Cardiohelp |
| Shockwave Medical, INC | $22.95 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.62 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.56 | 2025 | Jardiance |
| Bardy Diagnostics, INC. | $15.35 | 2022 | |
| Cardiovascular Systems INC. | $8.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Marr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.